Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis.
ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis.
Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis.
Effect of Estrogen on Th1, Th2 and Th17 Cytokine Production by Proteolipid Protein and PHA Activated Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Patients.
Role of microglia in CNS autoimmunity.
Cavernoma of the conus medullaris mimicking transverse myelitis.
The Development and Maintenance of Paclitaxel-Induced Neuropathic Pain Requires Activation of the Sphingosine 1-Phosphate Receptor Subtype 1.
Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.
Freedom from disease activity in multiple sclerosis.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Does the patient know best? Quality of life assessment in multiple sclerosis trials.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
[Recurring neuromyelitis without optic neuritis: a case report].
Origin and evolution of deep brain stimulation.
C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab.
Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy.
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.
Birth hospitalization in mothers with multiple sclerosis and their newborns.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
Pages
« first
‹ previous
…
201
202
203
204
205
206
207
208
209
…
next ›
last »